Advertisement

Worldwide Racial and Ethnic Distribution of α1-Antitrypsin Deficiency

Summary of an Analysis of Published Genetic Epidemiologic Surveys

      Study objectives

      α1-antitrypsin (AAT) deficiency is a genetic disease that is widely known in Europe as a disease of white individuals, who, along with their descendants in other parts of the world, are at the highest risk for liver and/or lung disease. There is a limited database of individuals affected by this disease worldwide. It has been estimated, for example, that there are 70,000 to 100,00 individuals affected in the United States, with comparable numbers in Europe.

      Study design

      Genetic epidemiologic studies in the peer-reviewed literature have been used in an exploratory study to estimate the number of carriers and the number of those individuals who are homozygous or heterozygous for the two most common defective alleles for AAT deficiency in 58 individual countries. The total country database of 373 control cohorts has been combined to estimate the numbers of carriers and deficiency allele combinations for PiS and PiZ in 11 geographic regions and worldwide. The study was designed to be illustrative rather than comprehensive, and more detailed publication of the enormous database developed in this exploratory study is planned.

      Conclusions

      The database presented indicates that in a total population of 4.4 billion in the countries surveyed worldwide, there are at least 116 million carriers (PiMS and PiMZ) and 3.4 million deficiency allele combinations (PiSS, PiSZ, and PiZZ). Furthermore, this database demonstrates that AAT deficiency is found in various populations of African blacks, Arabs and Jews in the Middle East, whites in Australia/New Zealand, Europe, and North America, central Asians, far east Asians, and southeast Asians. These data demonstrate that AAT deficiency is not just a disease of whites in Europe, but that it affects individuals in all racial subgroups worldwide. In addition, AAT deficiency may be one of the most common serious hereditary disorders in the world.

      Key words

      To read this article in full you will need to make a payment
      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Pierce JA
        Antitrypsin and emphysema: perspective and prospects.
        JAMA. 1988; 259: 2890-2895
        • Mahadeva R
        • Lomas DA
        Alpha(1)-antitrypsin deficiency, cirrhosis and emphysema.
        Thorax. 1998; 53: 501-505
        • Blyth B
        • Billingsley GD
        • Cox DW
        Physical and genetic mapping of the serpine gene cluster at 14q32.1: allelic association and a unique haplotype associated with alpha 1-antitrypsin deficiency.
        Am J Hum Genet. 1994; 55: 126-133
        • Blank CA
        • Brantly M
        Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency.
        Ann Allergy. 1994; 72: 105-120
        • Brantly M
        • Nukiwa T
        • Crystal RG
        Molecular basis of alpha-1-antitrypsin deficiency.
        Am J Med. 1988; 84: 13-31
        • Crystal RG
        • Brantly ML
        • Hubbard RC
        • et al.
        The alpha-1 antitrypsin gene and its mutations: clinical consequences and strategies for therapy.
        Chest. 1989; 95: 196-208
        • Cox DW
        • Woo SL
        • Mansfield T
        DNA restriction fragments associated with alpha 1-antitrypsin indicate a single origin for deficiency allele PI Z.
        Nature. 1985; 316: 79-81
        • Seixas S
        • Garcia O
        • Trovoada MJ
        • et al.
        Patterns of haplotype diversity within the serpine gene cluster at 14q32.1: insights into the natural history of the alpha1-antitrypsin polymorphism.
        Hum Genet. 2001; 108: 20-30
        • Hutchison DCS
        Alpha-1-antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z.
        Respir Med. 1998; 92: 367-377
        • World Health Organization
        Alpha 1-Pi deficiency: World Health Organization.
        Pneumologie. 1997; 51: 885-918
        • Endres W
        Inherited metabolic diseases affecting the carrier.
        J Inherit Metab Dis. 1997; 20: 9-20
        • Feld R
        Heterozygosity of alpha-1-antitrypsin: a health risk?.
        Crit Rev Clin Lab Sci. 1989; 27: 461-481
        • Gourley MF
        • Gourley GR
        • Gilbert EF
        • et al.
        Alpha 1-antitrypsin deficiency and the PiMS phenotype: case report and literature review.
        J Pediatr Gastroenterol Nutr. 1989; 8: 116-121
        • Nevo S
        Protease inhibitor subtypes in some population groups from Israel.
        Hum Hered. 1987; 37: 170-181
        • Blanco I
        • Fernandez E
        Alpha1-antitrypsin Pi phenotypes S and Z in Spain: an analysis of the published surveys.
        Respir Med. 2001; 95: 109-114
        • Blanco I
        • Fernandez E
        • Bustillo EF
        Alpha-1-antitrypsin PI phenotypes S and Z in Europe: an analysis of the published surveys.
        Clin Genet. 2001; 60: 31-41
        • Blanco I
        • Bustillo EF
        • Rodriguez MC
        Distribution of alpha-1-antitrypsin PI S and PI Z frequencies in countries outside of Europe: a meta-analysis.
        Clin Genet. 2001; 60: 431-441
        • Marini E
        • Moral P
        • Petralanda I
        • et al.
        Serum protein markers in the Piaroa indians of Amazonia (Venezuela).
        Hum Hered. 1993; 43: 232-238
        • Simoes AL
        • Kompf J
        • Ritter H
        • et al.
        Electrophoretic and isoelectric focusing studies in Brazilian Indians: data on four systems.
        Hum Biol. 1989; 61: 427-438
        • Vandeville D
        • Martin JP
        • Lebreton JP
        • et al.
        Pi system in Norman, and Amerindian populations.
        Rev Fr Transfus. 1972; 15: 213-218
        • Fonseca-Perez T
        • Gonzalez-Coira M
        • Arias S
        PI locus (alpha-1-antitrypsin) allelic frequencies in an Andean Venezuelan population.
        Gene Geogr. 1996; 10: 65-74
        • de Serres FJ
        • Blanco I
        • Bustillo EF
        Genetic epidemiology of alpha-1-antitrypsin deficiency in Southern Europe: France, Italy, Portugal, and Spain.
        Clin Genet. 2002; (in press)
        • Turino G
        • Barker AF
        • Brantly ML
        • et al.
        Clinical features of individuals with PI* SZ phenotype of alpha-1-antitrypsin deficiency: the Alpha-1-Antitrypsin Deficiency Registry Study Group.
        Am J Respir Crit Care Med. 1996; 154: 1718-1725
        • Lieberman J
        Heterozygous and homozygous alpha-1-antitrypsin deficiency in patients with pulmonary emphysema.
        N Engl J Med. 1969; 281: 279-284
        • Kueppers F
        • Fallat R
        • Larson RK
        Obstructive lung disease and alpha-1-antitrypsin deficiency heterozygosity.
        Science. 1969; 165: 899-901
        • Mittman C
        The PiMZ phenotype: is it a significant risk factor for the development of chronic obstructive lung disease?.
        Am Rev Respir Dis. 1978; 118: 649-652
        • Lieberman J
        • Silton RN
        • Agliozzo CM
        • et al.
        Hepatocellular carcinoma and intermediate alpha1-antitrypsin deficiency (MZ phenotype).
        Am J Clin Pathol. 1975; 64: 4-10
        • Cruz M
        • Molina JA
        • Pedrola D
        • et al.
        Cirrhosis and heterozygous alpha1-antitrypsin deficiency in a 4-year-old girl.
        Helv Paediatr Acta. 1976; 30: 501-507
        • Lolin YI
        • Ward AM
        Alpha-1-antitrypsin phenotypes and associated disease patterns in neurological patients.
        Acta Neurol Scand. 1995; 91: 394-398
        • Carlson J
        • Eriksson S
        Chronic “cryptogenic” liver disease and malignant hepatoma in intermediate alpha 1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody.
        Scand J Gastroenterol. 1985; 20: 835-842
        • Pittschieler K
        Liver disease and heterozygous alpha-1-antitrypsin deficiency.
        Acta Paediatr Scand. 1991; 80: 323-327
        • Pittschieler K
        Heterozygotes and liver involvement.
        Acta Paediatr. 1994; 393: 21-23
        • Lima LC
        • Matte U
        • Leistner S
        • et al.
        Molecular analysis of the Pi* Z allele in patients with liver disease.
        Am J Med Genet. 2001; 104: 287-290
        • Schievink WI
        • Katzmann JA
        • Piepgras DG
        Alpha-1-antitrypsin deficiency in spontaneous intracranial arterial dissections.
        Cerebrovasc Dis. 1998; 8: 42-44
        • Lieberman J
        • Winter B
        • Sastre A
        α1-antitrypsin Pi-types in 965 COPD patients.
        Chest. 1986; 89: 370-373
        • Graziadei IW
        • Joseph JJ
        • Wiesner RH
        • et al.
        Increased risk of chronic liver failure in adults with heterozygous alpha-1 antitrypsin deficiency.
        Hepatology. 1998; 28: 1058-1063
        • Colp C
        • Pappas J
        • Moran D
        • et al.
        Variants of alpha-1-antitrypsin in Puerto Rican children with asthma.
        Chest. 1993; 103: 812-815
        • Spitsyn VA
        • Nafikova AK
        • Spitsnya NK
        • et al.
        Genetic predisposition to development of toxic liver cirrhosis caused by alcohol.
        Genetika. 2001; 37: 698-707
        • Haywood J
        The Penguin historical atlas of the Vikings. Penguin Books, London, UK1995: 144
        • Chamberlin ER
        The bad Popes. Barnes and Noble Books, New York, NY1993: 310